Prospective Grant of Exclusive License: Cell Stress Transcriptional Factors

摘要

This is notice in accordance with 15 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive world-wide license to practice the invention embodied in U.S. Patent Application SN 07/617,910, entitled ``Cell Stress Transcriptional Factors'' to StressTech Biomedical, Inc. of San Francisco, CA. The patent rights in this invention have been assigned to the United States of America. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. It is anticipated that this license will be limited to the fields of commercial screening assay services and kits provided to third parties. This prospective exclusive license may be granted unless within 60 days from the date of this published notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The patent application is based upon the observation that activation of heat shock proteins in an organism indicates elevated or environmenta